> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Regulatory Review Period for Med–El EAS Hearing Device
- URL: https://www.fdaweb.com/regulatory-review-period-for-med-el-eas-hearing-device/
- Published: 2019-09-25T12:00:00.000Z
- Updated: 2026-09-15T01:52:23.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145089

*Federal Register* notice: FDA has determined for patent extension purposes the regulatory review period for Med-El Electromedizinische Gerate’s medical device Med–El EAS, intended to provide electrical stimulation to the mid- to high-frequency region of the cochlea and acoustic amplification to the low-frequency regions, for candidates with residual low-frequency hearing sensitivity. The regulatory review period is 4,537 days, which includes 4,269 days that occurred during the testing phase and 268 days during the approval phase. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-09-24/pdf/2019-20657.pdf?ref=fdaweb.com).